Verastem Inc (VSTM) financials

NASDAQ · Health Care

$9.75 +0.93% Close Oct 30, 2026 Live

Verastem revenue and earnings by year

Verastem's revenue was $30.9 million in the fiscal year to December 31, 2025, up 209.1% from the year before. Net income was -$209 million, -677.6% of revenue. Since the fiscal year to December 31, 2018, revenue has grown 2.1% a year on average.

RevenueNet income
-$200M-$100M$0
2018201920202021202220242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 7 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue311032891727
Revenue growth209.1%285.2%26.4%-97.7%407.1%-34.7%—
Gross profit26———551526
Gross margin82.9%———61.9%83.9%97.8%
Operating income-170-115-73-61-49-133-95
Operating margin-551.0%-1150.8%-2809.6%-2991.2%-55.8%-761.8%-354.8%
Net income-209-131-74-71-68-149-72
Net margin-677.6%-1306.4%-2843.3%-3468.1%-76.5%-854.8%-271.1%
Diluted EPS-$3.02-$3.66-$4.57-$4.90-$6.36-$24.12—
Free cash flow-138-105-64-54-34-139-98

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open VSTM in Markets.

See also: VSTM returns

No forecast, no recommendation. This page describes Verastem Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.